Leading Blog

MARCH 12, 2024

Given that the global biotechnology market was valued at USD 1.55 Some fail for a host of strategic or operational shortcomings addressed in any decent business school course. The likelihood of making beneficial decisions when facing the unexpected increases if we routinely practice certain values, skills, and approaches.

Tips 338

Tips Due Diligence Biotechnology Entrepreneur 338

N2Growth Blog

OCTOBER 23, 2023

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. One of the primary obstacles is the need for more highly skilled and qualified talent.

Execution 437

Execution Strategy Compliance Industry 437

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 8

Innovation Short-term Telecommunications Long-term 8

Harvard Business Review

JUNE 4, 2018

Although it’s hard to pinpoint when skills shortages became the norm in the U.S., ’s “once unchallenged preeminence in commerce, industry, science, and technological innovation is being overtaken by competitors throughout the world.” industries face acute skills shortages. Bernhard Lang/Getty Images.

Education 8

Education Company Biotechnology Human Capital 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

MARCH 5, 2012

And if you do not have local plants, you don't need to employ highly skilled technicians to maintain equipment. This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. But by the 1990s, the R&D had migrated there as well. The Right Policies.

Health Care 8

Health Care Biotechnology Industry Policies 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Customers Innovation Technology'

Uncertainty 19

Uncertainty Industry Bottom-up Technology 19